WO1993022292A1
(en)
*
|
1992-05-07 |
1993-11-11 |
Merck & Co., Inc. |
New quinazolines as inhibitors of hiv reverse transcriptase
|
DE4214829A1
(de)
*
|
1992-05-10 |
1993-11-11 |
Boehringer Mannheim Gmbh |
Verwendung von tricyclischen Pyrimidin-Derivaten als antivirale Arzneimittel
|
DE4214830A1
(de)
*
|
1992-05-10 |
1993-11-11 |
Boehringer Mannheim Gmbh |
Neue Tricyclische Thiazolo- und Thiazino-Derivate und diese enthaltende Arzneimittel
|
US6177435B1
(en)
|
1992-05-13 |
2001-01-23 |
Glaxo Wellcome Inc. |
Therapeutic combinations
|
ES2138624T3
(es)
*
|
1992-05-13 |
2000-01-16 |
Wellcome Found |
Combinaciones terapeuticas.
|
US5646154A
(en)
*
|
1992-10-07 |
1997-07-08 |
Sumitomo Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions for inhibiting the formation of tumor necrosis factor
|
WO1995012583A1
(en)
*
|
1993-11-05 |
1995-05-11 |
Merck & Co., Inc. |
New quinazolines as inhibitors of hiv reverse transcriptase
|
US5434152A
(en)
*
|
1993-11-08 |
1995-07-18 |
Merck & Co., Inc. |
Asymmetric synthesis of (S)-(-)-6-chloro-4- cyclopropyl-3,4-dihydro-4-[(2-pyridyl)ethynyl]-2(1H)-quinazolinone
|
DE4414476A1
(de)
*
|
1994-04-26 |
1995-11-02 |
Bayer Ag |
Substituierte Cyclopropylcarbonyl-phenylaminosulfonyl-harnstoffe
|
HRP980143A2
(en)
*
|
1997-04-09 |
1999-02-28 |
Soo Sung Ko |
4,4-disubstituted-3,4-dihydro-2 (1h)-quinazolinones useful as hiv reverse transcriptase inhibitors
|
US6124302A
(en)
*
|
1997-04-09 |
2000-09-26 |
Dupont Pharmaceuticals |
4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones useful as HIV reverse transcriptase inhibitors
|
CA2322203A1
(en)
*
|
1998-03-27 |
1999-10-07 |
Jeffrey W. Corbett |
4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthione derivatives, their preparation and their use as hiv reverse transcriptase inhibitors
|
US6391005B1
(en)
|
1998-03-30 |
2002-05-21 |
Agilent Technologies, Inc. |
Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
|
AU4698399A
(en)
*
|
1998-06-30 |
2000-01-17 |
Du Pont Pharmaceuticals Company |
1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
|
HRP990359A2
(en)
*
|
1998-11-19 |
2000-08-31 |
Du Pont Pharm Co |
A process for the preparation of quinazolinones
|
AU5588400A
(en)
*
|
1999-05-26 |
2000-12-18 |
Du Pont Pharmaceuticals Company |
1,4-benzodiazepin-2-ones useful as hiv reverse transcriptase inhibitors
|
US6593337B1
(en)
|
1999-10-19 |
2003-07-15 |
Bristol-Myers Squibb Pharma Company |
Tricyclic compounds useful as HIV reverse transcriptase inhibitors
|
DE19951702A1
(de)
*
|
1999-10-27 |
2001-05-03 |
Aventis Pharma Gmbh |
Verwendung von 2-Amino-3,4-dihydro-chinazolinen zur Herstellung eines Medikaments zur Behandlung oder Prophylaxe von durch ischämischen Zuständen bewirkten Krankheiten
|
US6175009B1
(en)
|
1999-11-18 |
2001-01-16 |
Dupont Pharmaceuticals Company |
Process for the preparation of quinazolinones
|
ATE296809T1
(de)
|
1999-11-23 |
2005-06-15 |
Smithkline Beecham Corp |
3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p38-kinase-inhibitoren
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
US6596729B2
(en)
*
|
2000-07-20 |
2003-07-22 |
Bristol-Myers Squibb Company |
Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
|
ZA200300255B
(en)
|
2000-07-20 |
2004-09-28 |
Bristol Myers Squibb Pharma Co |
Tricyclic 2-pyridone compounds useful as HIV reverse transcriptase inhibitors.
|
DK1333833T3
(da)
|
2000-10-23 |
2011-12-12 |
Glaxosmithkline Llc |
Ny trisubstitueret 8H-pyridol[2,3-d]pyrimidin-7-on-forbindelse til behandling af CSBP/RK/p38-kinnasemedierede sygdomme
|
US6435468B1
(en)
|
2000-10-26 |
2002-08-20 |
Dror Simchoni |
Rolling weighted base
|
US8641644B2
(en)
|
2000-11-21 |
2014-02-04 |
Sanofi-Aventis Deutschland Gmbh |
Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
|
US6946469B2
(en)
|
2001-03-28 |
2005-09-20 |
Bristol-Myers Squibb Pharma Company |
Cyanamide, alkoxyamino, and urea derivatives of 4,4-disubstituted-3,4-dihydro-2(1H)-quinazolinones as HIV reverse transcriptase inhibitors
|
AU2002258633A1
(en)
|
2001-03-28 |
2002-10-15 |
Bristol-Myers Squibb Company |
Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazapines as hiv reverse transcriptase inhibitors
|
MXPA03009482A
(es)
|
2001-04-19 |
2004-02-12 |
Bristol Myers Squibb Co |
Compuestos triciclicos utiles como inhibidores de la transcriptasa inversa del virus de inmunodeficiencia humana (vih).
|
US7981056B2
(en)
|
2002-04-19 |
2011-07-19 |
Pelikan Technologies, Inc. |
Methods and apparatus for lancet actuation
|
US7041068B2
(en)
|
2001-06-12 |
2006-05-09 |
Pelikan Technologies, Inc. |
Sampling module device and method
|
US9795747B2
(en)
|
2010-06-02 |
2017-10-24 |
Sanofi-Aventis Deutschland Gmbh |
Methods and apparatus for lancet actuation
|
JP4209767B2
(ja)
|
2001-06-12 |
2009-01-14 |
ペリカン テクノロジーズ インコーポレイテッド |
皮膚の性状の一時的変化に対する適応手段を備えた自動最適化形切開器具
|
DE60238119D1
(de)
|
2001-06-12 |
2010-12-09 |
Pelikan Technologies Inc |
Elektrisches betätigungselement für eine lanzette
|
AU2002348683A1
(en)
|
2001-06-12 |
2002-12-23 |
Pelikan Technologies, Inc. |
Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
|
US8337419B2
(en)
|
2002-04-19 |
2012-12-25 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
US9226699B2
(en)
|
2002-04-19 |
2016-01-05 |
Sanofi-Aventis Deutschland Gmbh |
Body fluid sampling module with a continuous compression tissue interface surface
|
US9427532B2
(en)
|
2001-06-12 |
2016-08-30 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
DE10161767A1
(de)
*
|
2001-12-15 |
2003-06-26 |
Merck Patent Gmbh |
2-Guanidino-4-heterocyclyl-chinazoline
|
US8267870B2
(en)
|
2002-04-19 |
2012-09-18 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for body fluid sampling with hybrid actuation
|
US7892183B2
(en)
|
2002-04-19 |
2011-02-22 |
Pelikan Technologies, Inc. |
Method and apparatus for body fluid sampling and analyte sensing
|
US7909778B2
(en)
|
2002-04-19 |
2011-03-22 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US8372016B2
(en)
|
2002-04-19 |
2013-02-12 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for body fluid sampling and analyte sensing
|
US9795334B2
(en)
|
2002-04-19 |
2017-10-24 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US7491178B2
(en)
|
2002-04-19 |
2009-02-17 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US9314194B2
(en)
|
2002-04-19 |
2016-04-19 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
US8784335B2
(en)
|
2002-04-19 |
2014-07-22 |
Sanofi-Aventis Deutschland Gmbh |
Body fluid sampling device with a capacitive sensor
|
US9248267B2
(en)
|
2002-04-19 |
2016-02-02 |
Sanofi-Aventis Deustchland Gmbh |
Tissue penetration device
|
US7229458B2
(en)
|
2002-04-19 |
2007-06-12 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7198606B2
(en)
|
2002-04-19 |
2007-04-03 |
Pelikan Technologies, Inc. |
Method and apparatus for a multi-use body fluid sampling device with analyte sensing
|
US8702624B2
(en)
|
2006-09-29 |
2014-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Analyte measurement device with a single shot actuator
|
US7901362B2
(en)
|
2002-04-19 |
2011-03-08 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US8579831B2
(en)
|
2002-04-19 |
2013-11-12 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US7297122B2
(en)
|
2002-04-19 |
2007-11-20 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7331931B2
(en)
|
2002-04-19 |
2008-02-19 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7175642B2
(en)
|
2002-04-19 |
2007-02-13 |
Pelikan Technologies, Inc. |
Methods and apparatus for lancet actuation
|
US7547287B2
(en)
|
2002-04-19 |
2009-06-16 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
CA2482022A1
(en)
|
2002-04-19 |
2003-10-30 |
Smithkline Beecham Corporation |
Novel compounds
|
US7232451B2
(en)
|
2002-04-19 |
2007-06-19 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US8360992B2
(en)
|
2002-04-19 |
2013-01-29 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US8221334B2
(en)
|
2002-04-19 |
2012-07-17 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for penetrating tissue
|
US7674232B2
(en)
|
2002-04-19 |
2010-03-09 |
Pelikan Technologies, Inc. |
Method and apparatus for penetrating tissue
|
US7976476B2
(en)
|
2002-04-19 |
2011-07-12 |
Pelikan Technologies, Inc. |
Device and method for variable speed lancet
|
TW200409629A
(en)
|
2002-06-27 |
2004-06-16 |
Bristol Myers Squibb Co |
2,4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
|
EP1400244A1
(en)
*
|
2002-09-17 |
2004-03-24 |
Warner-Lambert Company LLC |
New spirocondensed quinazolinones and their use as phosphodiesterase inhibitors
|
US8574895B2
(en)
|
2002-12-30 |
2013-11-05 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus using optical techniques to measure analyte levels
|
WO2004107975A2
(en)
|
2003-05-30 |
2004-12-16 |
Pelikan Technologies, Inc. |
Method and apparatus for fluid injection
|
WO2004107964A2
(en)
|
2003-06-06 |
2004-12-16 |
Pelikan Technologies, Inc. |
Blood harvesting device with electronic control
|
WO2006001797A1
(en)
|
2004-06-14 |
2006-01-05 |
Pelikan Technologies, Inc. |
Low pain penetrating
|
US8282576B2
(en)
|
2003-09-29 |
2012-10-09 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for an improved sample capture device
|
US9351680B2
(en)
|
2003-10-14 |
2016-05-31 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for a variable user interface
|
US7822454B1
(en)
|
2005-01-03 |
2010-10-26 |
Pelikan Technologies, Inc. |
Fluid sampling device with improved analyte detecting member configuration
|
WO2005065414A2
(en)
|
2003-12-31 |
2005-07-21 |
Pelikan Technologies, Inc. |
Method and apparatus for improving fluidic flow and sample capture
|
EP1751546A2
(en)
|
2004-05-20 |
2007-02-14 |
Albatros Technologies GmbH & Co. KG |
Printable hydrogel for biosensors
|
US9775553B2
(en)
|
2004-06-03 |
2017-10-03 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for a fluid sampling device
|
US9820684B2
(en)
|
2004-06-03 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Method and apparatus for a fluid sampling device
|
ATE527243T1
(de)
|
2005-03-09 |
2011-10-15 |
Merck Sharp & Dohme |
Calciumkanal-antagonisten vom typ chinazolinon t
|
AR053450A1
(es)
|
2005-03-25 |
2007-05-09 |
Glaxo Group Ltd |
Derivados de 3,4-dihidro-pirimido(4,5-d)pirimidin-2-(1h)-ona 1,5,7 trisustituidos como inhibidores de la quinasa p38
|
CA2603163A1
(en)
|
2005-03-25 |
2006-10-05 |
Glaxo Group Limited |
Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1h)-one derivatives
|
WO2006110298A2
(en)
|
2005-03-25 |
2006-10-19 |
Glaxo Group Limited |
8-alkyl/aryl-4-aryl-2-n- (alkylamino)-n'-substituted-n'-cyanoguanidino-8h-pyrido[2,3-d]pyrimidin-7-one compounds and use thereof
|
MY145281A
(en)
|
2005-03-25 |
2012-01-13 |
Glaxo Group Ltd |
Novel compounds
|
CA2610812A1
(en)
*
|
2005-06-14 |
2006-12-28 |
Schering Corporation |
Aspartyl protease inhibitors
|
WO2007022946A1
(de)
|
2005-08-21 |
2007-03-01 |
Abbott Gmbh & Co. Kg |
Heterocyclische verbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
|
CN101225083A
(zh)
*
|
2007-01-16 |
2008-07-23 |
北京摩力克科技有限公司 |
四氢喹唑啉酮类化合物及其用于制备治疗和预防病毒性疾病的药物的用途
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
US9603848B2
(en)
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
AU2013202912B2
(en)
*
|
2007-06-08 |
2016-10-27 |
Firmenich Incorporated |
Modulation of chemosensory receptors and ligands associated therewith
|
WO2009044788A1
(ja)
*
|
2007-10-05 |
2009-04-09 |
Banyu Pharmaceutical Co., Ltd. |
ベンゾオキサジノン誘導体
|
EP2265324B1
(en)
|
2008-04-11 |
2015-01-28 |
Sanofi-Aventis Deutschland GmbH |
Integrated analyte measurement system
|
WO2010014666A2
(en)
|
2008-07-31 |
2010-02-04 |
Senomyx, Inc. |
Processes and intermediates for making sweet taste enhancers
|
MX2011001155A
(es)
|
2008-07-31 |
2011-07-29 |
Senomyx Inc |
Composiciones que comprenden mejoradores del dulzor, y métodos para prepararlas.
|
US9375169B2
(en)
|
2009-01-30 |
2016-06-28 |
Sanofi-Aventis Deutschland Gmbh |
Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
|
US8965476B2
(en)
|
2010-04-16 |
2015-02-24 |
Sanofi-Aventis Deutschland Gmbh |
Tissue penetration device
|
EP2603098A4
(en)
|
2010-08-12 |
2018-01-17 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
CN102775371B
(zh)
*
|
2012-07-26 |
2015-01-21 |
山东大学 |
一种取代噻二嗪类衍生物及其制备方法与应用
|
BR112015002380B1
(pt)
|
2012-08-06 |
2021-09-28 |
Firmenich Incorporated |
Composto, composições ingeríveis, processos para aumentar o sabor doce de composição e formulação flavorizante concentrada
|
US8722886B1
(en)
*
|
2012-11-13 |
2014-05-13 |
Bionumerik Pharmaceuticals, Inc. |
Methods for the total chemical synthesis of enantiomerically-pure 7-(2′-trimethylsilyl)ethyl camptothecin
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
CN103360398B
(zh)
*
|
2013-07-22 |
2015-03-25 |
山东大学 |
一种三唑并嘧啶类hiv-1逆转录酶抑制剂及其制备方法与应用
|
EP3317278B1
(en)
|
2015-07-01 |
2021-04-14 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
US11028068B2
(en)
|
2017-07-25 |
2021-06-08 |
Crinetics Pharmaceuticals, Inc. |
Somatostatin modulators and uses thereof
|
MX2021001193A
(es)
|
2018-08-07 |
2021-04-28 |
Firmenich Incorporated |
2,2-dioxidos de 4-amino-1h-benzo[c][1,2,6]tiadiazina 5-sustituidos y formulaciones y usos de los mismos.
|
CN112480124A
(zh)
*
|
2020-12-16 |
2021-03-12 |
成都大学 |
三氟甲基取代的手性四氢吡咯[1,2-c]喹唑啉-3,5-二酮及其制备方法
|